Patents by Inventor Andreas Holm Mattsson

Andreas Holm Mattsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccines targeting Pseufomonas aeruginosa
    Publication number: 20190330281
    Abstract: Disclosed are immunogenic proteins from Pseudomonas aeruginosa as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or transformed cell.
    Type: Application
    Filed: January 5, 2018
    Publication date: October 31, 2019
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Proteins and nucleic acids useful in vaccines targeting
    Patent number: 10434162
    Abstract: The present invention relates to proteins and nucleic acids derived from Klebsiella pneumonia as well as therapeutic and diagnostic uses of the proteins and nucleic acids.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: October 8, 2019
    Assignee: Evaxion Biotech ApS
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Chimeric proteins for inducing immunity towards infection with S. aureus
    Publication number: 20190241623
    Abstract: Disclosed is chimeric polypeptides derived from S. aureus proteins having SEQ ID NOs: 1-9 and 139-146. The chimeric polypeptides are useful as immunogens for providing protective immunity against S. aureus infection. Also disclosed are compositions, methods of treatment and prophylaxis, nucleic acids and vectors comprising the nucleic acids.
    Type: Application
    Filed: July 24, 2017
    Publication date: August 8, 2019
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson, Jens Kringelum
  • Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
    Publication number: 20190046631
    Abstract: The present invention relates to proteins and nucleic acids derived from Staphylococcus aureus as well as therapeutic and diagnostic uses of the proteins and nucleic acids.
    Type: Application
    Filed: February 22, 2017
    Publication date: February 14, 2019
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Proteins and nucleic acids useful in vaccines targeting Klebsiella Pneumoniae
    Publication number: 20190015496
    Abstract: The present invention relates to proteins and nucleic acids derived from Klebsiella pneumonia as well as therapeutic and diagnostic uses of the proteins and nucleic acids.
    Type: Application
    Filed: January 12, 2016
    Publication date: January 17, 2019
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
    Publication number: 20180296659
    Abstract: Disclosed are novel immunogenic proteins derived from Staphylococcus aureus, as well as methods for their use in conferring protective immunity against S. aureus infections. Also disclosed are nucleic acids encoding the proteins and methods of use of these nucleic acids.
    Type: Application
    Filed: June 29, 2018
    Publication date: October 18, 2018
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Proteins and nucleic acids useful in vaccines targeting
    Patent number: 10034928
    Abstract: Disclosed are novel immunogenic proteins derived from Staphylococcus aureus, as well as methods for their use in conferring protective immunity against S. aureus infections. Also disclosed are nucleic acids encoding the proteins and methods of use of these nucleic acids.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: July 31, 2018
    Assignee: Evaxion Biotech ApS
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Proteins and nucleic acids useful in vaccines targeting Pseudomonas Aeruginosa
    Publication number: 20180201656
    Abstract: Disclosed are immunogenic proteins from Pseudomonas aeruginosa as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or transformed cells.
    Type: Application
    Filed: July 4, 2016
    Publication date: July 19, 2018
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Peptides derived from acinetobacter baumannii and their use in vaccination
    Publication number: 20180169211
    Abstract: The present invention relates to proteins derived from Acinetobacter Baumanii, nucleic acids encoding the proteins, antibodies specific for the proteins as well as methods of therapy, prophylaxis, and diagnosis that utilize the proteins, nucleic acids, and antibodies.
    Type: Application
    Filed: November 13, 2015
    Publication date: June 21, 2018
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS
    Publication number: 20170100470
    Abstract: Disclosed are novel immunogenic proteins derived from Staphylococcus aureus, as well as methods for their use in conferring protective immunity against S. aureus infections. Also disclosed are nucleic acids encoding the proteins and methods of use of these nucleic acids.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 13, 2017
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Proteins and nucleic acids useful in vaccines targeting
    Patent number: 9534022
    Abstract: Disclosed are novel immunogenic proteins derived from Staphylococcus aureus, as well as methods for their use in conferring protective immunity against S. aureus infections. Also disclosed are nucleic acids encoding the proteins and methods of use of these nucleic acids.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: January 3, 2017
    Assignee: NovVac APS
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
    Publication number: 20160368952
    Abstract: The present invention relates to proteins and nucleic acids derived from Staphylococcus aureus as well as therapeutic and diagnostic uses of the proteins and nucleic acids.
    Type: Application
    Filed: December 3, 2014
    Publication date: December 22, 2016
    Inventors: Niels Iversen MOLLER, Andreas Holm MATTSSON
  • Peptides derived from Campylobacter jejuni and their use in vaccination
    Publication number: 20160168208
    Abstract: Disclosed are polypeptides for Campylobacter jejuni that are useful as immunogenic agents for vaccine use. Also disclosed are nucleic acid fragments encoding the polypeptides as well as compositions, methods and molecular biology tools derived from or related to the proteins.
    Type: Application
    Filed: February 25, 2016
    Publication date: June 16, 2016
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS
    Publication number: 20150322117
    Abstract: Disclosed are novel immunogenic proteins derived from Staphylococcus aureus, as well as methods for their use in conferring protective immunity against S. aureus infections. Also disclosed are nucleic acids encoding the proteins and methods of use of these nucleic acids.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson